Research programme: antimalarials - MRC Technology

Drug Profile

Research programme: antimalarials - MRC Technology

Alternative Names: ABC-120; Anti-malaria antibody - MRC Technology; Antimalarial humanised antibody - MRC Technology; Antimalarials research programme - MRC Technology

Latest Information Update: 20 Feb 2017

Price : $50

At a glance

  • Originator AERES Biomedical
  • Developer MRC Technology
  • Class Antibodies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Malaria

Most Recent Events

  • 10 Sep 2005 This programme is still in active development
  • 10 Jul 2003 Preclinical trials in Malaria in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top